BATS BZX Real-Time Price
As of 1:25pm ET
| +0.11 / +0.93%|
The 5 analysts offering 12-month price forecasts for Merrimack Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 16.00 and a low estimate of 13.00. The median estimate represents a +8.42% increase from the last price of 11.99.
The current consensus among 6 polled investment analysts is to Buy stock in Merrimack Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.